Antisense modulation of zinc finger protein-217 expression
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jun 5, 2001
Grant Date -
N/A
app pub date -
Apr 28, 2000
filing date -
Apr 28, 2000
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of zinc finger protein-217. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding zinc finger protein-217. Methods of using these compounds for modulation of zinc finger protein-217 expression and for treatment of diseases associated with expression of zinc finger protein-217 are provided.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully